Some of these had STAT3 signaling as a target: sunitinib reversed tumor MDSC accumulation through STAT3 or c-Kit signaling, and metformin downregulated the function of MDSCs through the AMPK/STAT3 pathway. This evidence concerns the gene STAT3 and neoplasm.